ASX Health Stocks: Memphasys plans in vivo studies in Japan,

ASX Health Stocks: Memphasys plans in vivo studies in Japan, Canada; ECS sells Tassie assets

Related Keywords

Monash , South Australia , Australia , Malaysia , Japan , United States , United Kingdom , Singapore , China , Indonesia , Canada , Adelaide , Australian , Susan Mollan , Nan Maree Schoerie , Michael Knaap , University Hospital Birmingham , University Hospital , Group Ltd , Australian Government Medical Research Future Fund , Medtronic , Direct Selling Group , Felix System , Maree Schoerie , Direct Selling Business , Australian Government , Medical Research Future Fund , Clinical Translation , Commercialisation Medtech ,